12
S. Paul et al. / Tetrahedron xxx (2013) 1e13
9.1.5. 1,5-Cyclooctadienyl-(S)-(5-(fluoromethyl)-2-phenyl-6,7-
dihydro-2H-pyrrolo[2,1-c][1,2,4]-triazol-3(5H)-ylidene)rhodium(I)
chloride (34). A freshly prepared solution of NaH (9.6 mg,
0.24 mmol, 60% dispersion in mineral oil) in EtOH (1.2 ml) was
added slowly to a suspension of [Rh(COD)Cl]2 (29.6 mg, 0.06 mmol)
in EtOH (0.8 ml). After stirring at rt for 45 min, 19 (36.6 mg,
0.12 mmol) was added and the mixture was stirred for a further
24 h at rt. The solvent was removed in vacuo and the crude product
was purified by column chromatography (cyclohexane/ethyl ace-
tate 1/0/1/2) to yield the product as a pale brown solid (26 mg,
47%) [Found: C, 51.91; H, 5.30; N, 8.92; F, 3.96; Cl, 7.81.
d
177.2, 140.2, 129.9, 129.3, 125.0, 123.7, 122.5, 119.1, 82.3, 61.3, 51.1;
19F NMR (376.5 MHz, CDCl3)
d
ꢁ78.2 (s, 3F, OTf), ꢁ222.2 (tt, J¼47.3,
27.9 Hz, 2F, CH2F); IR (neat) 3097, 2920, 2851, 1598, 1497, 1415,1363,
1261, 1221, 1141, 1101, 1030, 1013, 909, 863, 768, 741, 694, 635; mass
spectrum HRMS (ESIþ) m/z: (Mþ) found, 527.1241. C25H27F2N4Pd
requires 527.1243.
9.1.8. Allyl-bis(4-(2-fluoroethyl)-1-phenyl-1H-1,2,4-triazol-5(4H)-
ylidene)palladium(II) triflate (39). Bis(4-(2-fluoroethyl)-1-phenyl-
1H-1,2,4-triazol-5(4H)ylidene) silver (I) triflate 37 (23 mg,
0.036 mmol) and [Pd(allyl)Cl]2 (12.6 mg, 0.035 mmol) were dis-
solved in CH2Cl2 (0.7 ml) and the mixture was stirred at rt for 24 h.
The resulting suspension was filtered through a short pad of Celite
and the filtrate concentrated to give a crude product, which was
then purified by column chromatography (CH2Cl2/MeOH 50/
0/20/5) to furnish the product as a white solid (19.1 mg, 78%). Mp:
115 ꢀC (decomposition); Rf 0.31 (CH2Cl2/MeOH 9/1); 1H NMR
C
20H24N3FClRh requires C, 51.80; H, 5.22; N, 9.06; F, 4.10; Cl, 7.64].
Mp: 198 ꢀC (decomposition); Rf 0.49 (cyclohexane/ethyl acetate 1/
1); ½a 2D0
ꢃ
ꢁ84.0 (c 0.1, CH2Cl2); 1H NMR (400 MHz, CDCl3)
d 8.43 (d,
J¼7.6 Hz, 2H, H9, H13), 7.56e7.52 (m, 2H, H10, H12), 7.47e7.43 (m,
1H, H11), 6.53 (dd, J¼48.4, 10.1 Hz, 1H, H6), 5.21e5.17 [m, 1H,
CH(COD)], 5.10e4.97 [m, 2.5H, H6, H5, CH(COD)], 4.87 (d, J¼10.2 Hz,
0.5H, H6), 3.35 [s, br, 1H, CH(COD)], 3.07e2.94 (m, 2H, H3),
2.87e2.73 [m, 3H, H4, CH(COD)], 2.37e2.26 [m, 3H, CH2(COD)],
1.94e1.77 [m, 4H, CH2(COD)], 1.67e1.59 [m, 1H, CH2(COD)]; 13C
(400 MHz, CD2Cl2)
d
8.28 (d, J¼1.1 Hz, 2H, H3), 7.52e7.48 (m, 6H,
H5, H6, H7), 7.39e7.36 (m, 2H, H5, H6), 5.56 (tt, J¼13.2, 7.3 Hz, 1H,
H10), 4.63e4.54 (m, 2H, H1), 4.52e4.42 (m, 2H, H1), 4.18 (d,
J¼7.4 Hz, 2H, H9 or H11), 3.94e3.91 (m, 2H, H2), 3.87e3.84 (m, 2H,
H2), 2.97 (d, J¼13.2 Hz, 2H, H9 or H11); 13C NMR (100 MHz, CD2Cl2)
NMR (100 MHz, CDCl3)
99.15, 99.06, 82.7, 71.1, 69.6, 58.0, 33.1, 32.0, 29.2, 28.7, 28.3, 21.2; 19
(376.6 MHz, CDCl3)
d 181.4, 160.8, 140.6, 128.8, 128.5, 124.0,
F
d
ꢁ236.8; IR (neat) 2939, 2229,1967,1596,1493,
d 180.9, 144.4, 139.9,130.4,130.3,124.7, 120.9, 82.3,121.5, 63.9, 49.7;
1449, 1331, 1069, 973, 910, 865, 812, 760, 725, 693, 639; mass
19F NMR (376.5 MHz, CD2Cl2)
d
ꢁ78.9 (s, 3F, OTf), ꢁ222.4 (tt, J¼47.2,
spectrum HRMS (ESIþ) m/z: (MþꢁCl), found 428.0999.
28.0 Hz, 2F, CH2F); IR (neat) 3119, 2924, 1597, 1539, 1499, 1463,
1409, 1374, 1357, 1263, 1220, 1151, 1076, 1029, 961, 911, 858, 766,
718, 696, 634; mass spectrum HRMS (ESIþ) m/z: (Mþ) found,
529.1133. C23H25F2N6Pd requires 529.1147.
Full experimental details are provided in the Supplementary
data.
C
20H24FN3Rh requires 428.1004.
9.1.6. 1,5-Cyclooctadienyl-(S)-(5-(fluoromethyl)-2-phenyl-6,7-
dihydro-2H-pyrrolo[2,1-c][1,2,4]-triazol-3(5H)-ylidene)iridium(I)
chloride (35). A freshly prepared solution of NaH (2.4 mg,
0.06 mmol, 60% dispersion in mineral oil) in EtOH (0.3 ml) was
added slowly to a suspension of [Ir(COD)Cl]2 (10.1 mg, 0.015 mmol)
in EtOH (0.2 ml). After stirring at rt for 45 min, 19 (18.3 mg,
0.06 mmol) was added and the mixture was stirred for a further
24 h at rt. The solvent was evaporated and the crude product was
purified by column chromatography (cyclohexane/ethyl acetate 2/
1) to yield the product as a pale brown solid (6 mg, 36%). Mp: 175 ꢀC
Acknowledgements
We gratefully acknowledge generous financial support from the
€
Alfred Werner Foundation, the ETH Zurich, the University of Glas-
gow and the Westfalische Wilhelms-Universitat Munster.
€
€
€
(decomposition); Rf 0.74 (CH2Cl2/MeOH 20/1); ½a D20
ꢁ6.6 (c 0.06,
ꢃ
Supplementary data
CH2Cl2); 1H NMR (400 MHz, CDCl3)
d 8.30e8.29 (m, 2H, H9, H13),
7.50e7.43 (m, 3H, H10, H11, H12), 6.19 (dd, J¼47.8, 9.7 Hz, 1H, H6),
5.01e4.65 [m, 4H, H5, H6, 2ꢄ CH(COD)], 3.08e3.02 (m, 2H, H3),
2.89e2.76 [m, 3H, H4, CH(COD)], 2.45e2.40 [m, 1H, CH(COD)],
2.21e2.11 [m, 3H, CH2(COD)], 1.84e1.76 [m, 1H, CH2(COD)],
1.72e1.64 [m, 2H, CH2(COD)], 1.58e1.48 [m, 1H, CH2(COD)],
Supplementary data related to this article can be found at
References and notes
1.44e1.37 [m, 1H, CH2(COD)]; 13C NMR (100 MHz, CDCl3)
d 179.0,
1. (a) Zimmer, L. E.; Sparr, C.; Gilmour, R. Angew. Chem. 2011, 123, 12062e12074;
Angew. Chem., Int. Ed. 2011, 50, 11860e11871; (b) Hunter, L. Beilstein J. Org. Chem.
2. DiRocco, D. A.; Oberg, K. M.; Dalton, D. M.; Rovis, T. J. Am. Chem. Soc. 2009, 131,
10872e10874.
3. Ritter, T.; Day, M. W.; Grubbs, R. J. Am. Chem. Soc. 2006, 128, 11768e11769.
4. DiRocco, D. A.; Noey, E. L.; Houk, K. N.; Rovis, T. Angew. Chem. 2012, 124,
2441e2444; Angew. Chem., Int. Ed. 2012, 51, 2391e2394.
5. For an excellent review see Plenio, H. Chem. Rev. 1997, 97, 3363e3384.
6. For a recent theoretical treatment of the gauche effect in substituted fluoro-
ethanes see: Buissonneaud, D. Y.; Van Mourik, T.; O’Hagan, D. Tetrahedron 2010,
66, 2169e2202 and references cited therein.
160.5, 140.4, 128.7, 128.3, 124.1, 86.4, 86.35, 82.6, 57.8, 54.8, 53.3,
33.3, 33.2, 29.9, 29.2, 28.4, 21.3; 19F NMR (376.6 MHz, CDCl3)
d
ꢁ236.9; IR (neat) 2921, 1969, 1729, 1595, 1498, 1448, 1384, 1353,
1287, 1155, 1066, 1018, 981, 934, 817, 765, 692; mass spectrum
HRMS (MALDIþ) m/z: (MþꢁCl) found: 518.1578. C20H24FIrN3 re-
quires 518.1579.
9.1.7. Allyl-bis(1-(2-fluoroethyl)-3-phenyl-1H-imidazol-2(3H)-yli-
dene)palladium(II) triflate (38). Bis(1-(2-fluoroethyl)-3-phenyl-1H-
imidazol-2(3H)-ylidene) silver(I) triflate 36 (31 mg, 0.0486 mmol)
and [Pd(allyl)Cl]2 (17 mg, 0.0486 mmol) were dissolved in CH2Cl2
(1 ml) and the mixture was stirred at rt for 19 h. The resulting
suspension was filtered through a short pad of Celite and the filtrate
was concentrated to give a yellow oil, which was purified by col-
umn chromatography (CH2Cl2/MeOH 50/1) to yield the product as
a white solid (19.1 mg, 58%). Mp: 134.3e136.2 ꢀC; Rf 0.47 (CH2Cl2/
7. For examples from this laboratory see: (a) Sparr, C.; Schweizer, W. B.; Senn, H.
M.; Gilmour, R. Angew. Chem. 2009, 121, 3111e3114; Angew. Chem., Int. Ed. 2009,
48, 3065e3068; (b) Sparr, C.; Tanzer, E.-M.; Bachmann, J.; Gilmour, R. Synthesis
ꢁ
2010, 1394e1397; (c) Seebach, D.; Gilmour, R.; Groselj, U.; Deniau, G.; Sparr, C.;
ꢁ
ꢁ
Ebert, M.-O.; Beck, A. K.; McCusker, L. B.; Sisak, D.; Uchimaru, T. Helv. Chim. Acta
2010, 93, 603e634; (d) Bucher, C.; Mondelli, C.; Baiker, A.; Gilmour, R. J. Mol.
Catal. A: Chem. 2010, 327, 87e91; (e) Sparr, C.; Gilmour, R. Angew. Chem. 2010,
122, 6670e6673; Angew. Chem., Int. Ed. 2010, 49, 6520e6523; (f) Tanzer, E.-M.;
Schweizer, W. B.; Ebert, M.-O.; Gilmour, R. Chem.dEur. J. 2012, 18, 2006e2013;
(g) Tanzer, E.-M.; Zimmer, L. E.; Schweizer, W. B.; Gilmour, R. Chem.dEur. J.
2012, 18, 11334e11342.
MeOH 9/1); 1H NMR (400 MHz, CDCl3)
d 7.47e7.44 (m, 6H, H6, H7,
8. Irwin, J. J.; Ha, T.-K.; Dunitz, J. D. Helv. Chim. Acta 1990, 73, 1805e1817.
9. Paul, S.; Schweizer, W. B.; Ebert, M.-O.; Gilmour, R. Organometallics 2010, 29,
data for the type 7 Au(NHC)Cl complex: Orthorhombic; Space group P212121;
H8), 7.25e7.24 (m, 2H, H3), 7.15e7.14 (m, 2H, H4), 7.09e7.07 (m, 4H,
H6, H7, H8), 5.28 (tt, J¼13.2, 7.3 Hz, 1H, H11), 4.52 (dm, J¼47.3 Hz,
4H, H1), 3.88 (d, J¼7.3 Hz, 2H, H10 or H12), 3.68 (dm, J¼27.7 Hz, 2H,
H2), 2.59 (d, J¼13.2 Hz, 2H, H10 or H12); 13C NMR (100 MHz, CDCl3)
a¼9.8352 A; b¼9.8352 A; c¼27.0406 A; d[AueAu]¼3.31 A; f[NCCF]¼ꢁ61.9ꢀ/ꢁ48.
ꢀ
ꢀ
ꢀ
ꢀ